Attached files
| file | filename |
|---|---|
| EX-4.7 - EX-4.7 - ENDOCYTE INC | f56327a2exv4w7.htm |
| EX-3.5 - EX-3.5 - ENDOCYTE INC | f56327a2exv3w5.htm |
| EX-3.3 - EX-3.3 - ENDOCYTE INC | f56327a2exv3w3.htm |
| EX-3.2 - EX-3.2 - ENDOCYTE INC | f56327a2exv3w2.htm |
| EX-3.1 - EX-3.1 - ENDOCYTE INC | f56327a2exv3w1.htm |
| EX-10.18 - EX-10.18 - ENDOCYTE INC | f56327a2exv10w18.htm |
| EX-10.17 - EX-10.17 - ENDOCYTE INC | f56327a2exv10w17.htm |
| EX-10.19 - EX-10.19 - ENDOCYTE INC | f56327a2exv10w19.htm |
| S-1/A - S-1/A - ENDOCYTE INC | f56327a2sv1za.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report
dated April 22, 2010, in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-268904)
and related Prospectus of Endocyte, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Indianapolis, IN
December 14, 2010
December 14, 2010